FAR1

fatty acyl-CoA reductase 1, the group of Short chain dehydrogenase/reductase superfamily

Basic information

Region (hg38): 11:13668659-13732346

Previous symbols: [ "MLSTD2" ]

Links

ENSG00000197601NCBI:84188OMIM:616107HGNC:26222Uniprot:Q8WVX9AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • fatty acyl-CoA reductase 1 deficiency (Moderate), mode of inheritance: AR
  • fatty acyl-CoA reductase 1 deficiency (Strong), mode of inheritance: AR
  • fatty acyl-CoA reductase 1 deficiency (Supportive), mode of inheritance: AR
  • hereditary spastic paraplegia 9A (Supportive), mode of inheritance: AD
  • spastic paraparesis-cataracts-speech delay syndrome (Strong), mode of inheritance: AD
  • fatty acyl-CoA reductase 1 upregulation (Moderate), mode of inheritance: AD
  • fatty acyl-CoA reductase 1 deficiency (Moderate), mode of inheritance: AR
  • fatty acyl-CoA reductase 1 deficiency (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Cataracts, spastic paraparesis, and speech delay; Peroxisomal fatty acyl-CoA reductase 1 disorderAD/ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingBiochemical; Craniofacial; Neurologic; Ophthalmologic26220973; 33239752

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the FAR1 gene.

  • not_provided (355 variants)
  • Inborn_genetic_diseases (36 variants)
  • Fatty_acyl-CoA_reductase_1_deficiency (10 variants)
  • CATARACTS,_SPASTIC_PARAPARESIS,_AND_SPEECH_DELAY (6 variants)
  • FAR1-related_disorder (5 variants)
  • not_specified (4 variants)
  • CATARACTS,_SPASTIC_PARAPLEGIA,_AND_SPEECH_DELAY (3 variants)
  • FAR1-related_neurodevelopmental_disorder (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the FAR1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000032228.6. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
5
clinvar
93
clinvar
1
clinvar
99
missense
2
clinvar
5
clinvar
156
clinvar
4
clinvar
167
nonsense
4
clinvar
1
clinvar
5
start loss
1
1
frameshift
1
clinvar
1
clinvar
2
splice donor/acceptor (+/-2bp)
1
clinvar
1
clinvar
2
Total 7 7 164 97 1

Highest pathogenic variant AF is 0.00000434331

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
FAR1protein_codingprotein_codingENST00000354817 1163677
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9850.0150125631041256350.0000159
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense3.301242790.4440.00001453395
Missense in Polyphen955.9620.16082714
Synonymous0.5348995.60.9310.00000496958
Loss of Function4.18326.00.1160.00000133315

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00006160.0000615
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00001770.0000176
Middle Eastern0.000.00
South Asian0.00003410.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Catalyzes the reduction of saturated and unsaturated C16 or C18 fatty acyl-CoA to fatty alcohols (PubMed:15220348, PubMed:24108123). It plays an essential role in the production of ether lipids/plasmalogens which synthesis requires fatty alcohols (PubMed:20071337, PubMed:24108123). In parallel, it is also required for wax monoesters production since fatty alcohols also constitute a substrate for their synthesis (By similarity). {ECO:0000250|UniProtKB:Q922J9, ECO:0000269|PubMed:15220348, ECO:0000269|PubMed:20071337, ECO:0000269|PubMed:24108123}.;
Disease
DISEASE: Peroxisomal fatty acyl-CoA reductase 1 disorder (PFCRD) [MIM:616154]: An autosomal recessive metabolic disorder clinically characterized by severe intellectual disability, early-onset epilepsy, microcephaly, congenital cataracts, growth retardation, and spasticity. {ECO:0000269|PubMed:25439727}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Peroxisome - Homo sapiens (human);miR-targeted genes in epithelium - TarBase;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase;Metabolism of lipids;Metabolism;Wax biosynthesis (Consensus)

Recessive Scores

pRec
0.107

Intolerance Scores

loftool
0.345
rvis_EVS
-0.21
rvis_percentile_EVS
38.58

Haploinsufficiency Scores

pHI
0.430
hipred
Y
hipred_score
0.685
ghis
0.581

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
H
gene_indispensability_pred
E
gene_indispensability_score
0.843

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Far1
Phenotype

Gene ontology

Biological process
ether lipid biosynthetic process;wax biosynthetic process;long-chain fatty-acyl-CoA metabolic process;glycerophospholipid biosynthetic process;oxidation-reduction process
Cellular component
peroxisome;peroxisomal membrane;integral component of peroxisomal membrane;peroxisomal matrix
Molecular function
oxidoreductase activity;fatty-acyl-CoA reductase (alcohol-forming) activity;alcohol-forming fatty acyl-CoA reductase activity